{"id":"W4390545534","doi":"10.1002/pul2.12323","title":"CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial","year":2024,"lang":"en","type":"article","venue":"Pulmonary Circulation","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Abbott (Canada)","funders":"Daiichi Sankyo Europe; Duke Clinical Research Institute; St. Jude Medical; Boston Scientific Corporation; Cleveland Clinic","keywords":"Medicine; Tolerability; Pulmonary hypertension; Adverse effect; Clinical trial; Clinical endpoint; Phases of clinical research; Internal medicine; Surrogate endpoint; Pulmonary artery; Blood pressure; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003540147,0.0001946058,0.0006750789,0.0002768407,0.00008678997,0.00001133432,0.0000449519,0.000106215,0.00002999635],"category_scores_gemma":[0.0001677171,0.000110344,0.000264536,0.0003270512,0.000132252,0.0001759216,0.00001104442,0.0000594651,0.000001235421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005066174,"about_ca_system_score_gemma":0.0002454038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000154339,"about_ca_topic_score_gemma":6.209335e-7,"domain_scores_codex":[0.9980633,0.000144959,0.000806522,0.0003342989,0.00047727,0.000173618],"domain_scores_gemma":[0.9977939,0.001119941,0.0002572194,0.0002743471,0.0004414493,0.0001131961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.7374635,0.02765463,0.0223014,0.0005362406,0.002004975,0.0002688355,0.0001454853,0.0003795387,0.02542788,0.0002139351,0.00006029426,0.1835433],"study_design_scores_gemma":[0.2283312,0.02155548,0.2535096,0.0002860301,0.002335679,0.0001221714,0.00006226818,0.4914917,0.0009590002,0.0006624741,0.0004770596,0.0002073327],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842343,0.002456137,0.004947105,0.0002651948,0.0001958596,0.007687847,0.0001727259,0.00001990472,0.00002089751],"genre_scores_gemma":[0.9976976,0.0003263727,0.000625579,0.00001733934,0.0001895565,0.0004526756,0.000617745,0.00002483901,0.0000483044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5091323,"threshold_uncertainty_score":0.4499696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08435669677534527,"score_gpt":0.3459223586697776,"score_spread":0.2615656618944323,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}